Early Phase I Study of a <sup>99m</sup>Tc-Labeled Anti–Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non–Small Cell Lung CancerYan Xing, Jinhua Zhao, Hong Hoi Ting et al.|Journal of Nuclear Medicine|2019Cited by 164
Improved amyloid burden quantification with nonspecific estimates using deep learningHaohui Liu, Anthonin Reilhac, Bibek Gyanwali et al.|European Journal of Nuclear Medicine and Molecular Imaging|2021Cited by 25